Drug-drug Interaction Study of Rifampin and Anaprazole Sodium
Clinical trial NCT07330531 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07330531
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-04
- Primary completion
- 2026-02-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.